Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy

Despite the significant progress of modern anticancer therapies, multiple myeloma (MM) is still incurable for the majority of patients. Following almost three decades of development, chimeric antigen receptor (CAR) T-cell therapy now has the opportunity to revolutionize the treatment landscape and m...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Ewelina Grywalska, Barbara Sosnowska-Pasiarska, Jolanta Smok-Kalwat, Marcin Pasiarski, Paulina Niedźwiedzka-Rystwej, Jacek Roliński
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	MDPI AG 2020-04-01
Serie:	Cells
Ämnen:	multiple myeloma chimeric antigen receptor T (CAR T) BCMA immunotherapy
Länkar:	https://www.mdpi.com/2073-4409/9/4/983
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!